Teva Pharmaceutical Industries Limited ( TEVJF) - Key Metrics
TEVJF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $3.56 | -$0.49 | $0.35 | $0.26 |
| 2026Q1 | $3.44 | $0.32 | -$0.03 | -$0.18 |
| 2025Q4 | $4.10 | $0.43 | $1.01 | $0.63 |
| 2025Q3 | $3.92 | $0.38 | $0.32 | $0.20 |
| 2025Q2 | $3.64 | $0.25 | $0.20 | $0.11 |
TEVJF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -15.48 |
| 2026Q1 | 0% | 22.16 |
| 2025Q4 | 0% | 16.63 |
| 2025Q3 | 0% | 13.16 |
| 2025Q2 | 0% | 17.80 |
TEVJF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.87% | 0% |
| 2026Q1 | -0.63% | 0% |
| 2025Q4 | 2.20% | 0% |
| 2025Q3 | 1.02% | 0% |
| 2025Q2 | 0.64% | 0% |
TEVJF
Price: $38.98
52 week price:
Dividend Yield: 3.01%
Payout Ratio Range:
Earnings Per Share: 0.60 USD
P/E Ratio: 47.33
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 45.4 billion